Octopus Biosafety Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	22	3	3	2	3	6
Market Cap Growth	1370.41%	-11.91%	83.04%	-46.82%	-45.38%	238.82%
Enterprise Value	22	3	6	3	3	5
Last Close Price	0.17	0.18	0.21	0.42	0.79	1.44
PS Ratio	56.45	7.10	4.74	6.11	5.94	8.82
PB Ratio	-33.14	-4.17	989.38	-1.18	-5.02	15.58
P/TBV Ratio	-	-	-	-	-	19.19
EV/Sales Ratio	57.81	7.69	8.76	12.04	5.52	7.83
Debt / Equity Ratio	-0.83	-0.83	112.61	-1.87	-2.71	1.24
Net Debt / Equity Ratio	-0.80	-0.80	72.50	-1.83	-2.59	-0.60
Net Debt / EBITDA Ratio	-3.39	-3.39	-0.42	-5.53	-2.70	0.24
Asset Turnover	0.61	0.61	0.55	0.17	0.27	0.40
Inventory Turnover	20.57	20.57	1.89	0.54	1.22	3.29
Quick Ratio	0.30	0.30	1.12	0.14	0.84	1.62
Current Ratio	0.32	0.32	1.28	0.43	1.77	2.12
Return on Assets (ROA)	-83.06%	-83.06%	-74.79%	-27.25%	-35.70%	-52.45%
Return on Capital Employed (ROCE)	170.40%	170.40%	-419.70%	80.90%	-98.60%	-91.70%
Earnings Yield	-3.03%	-24.10%	-57.24%	-47.33%	-31.68%	-14.25%
Buyback Yield / Dilution	-269.15%	-1.32%	-264.33%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.